Buspirone Hydrochloride

Product NDC
71610-257
Requested package NDC
71610-257-53
11-digit product format
716100257
Labeler code
71610
Product ID
71610-257_4f71daa2-f021-bcb6-e063-6394a90a28b7
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Buspirone Hydrochloride
Dosage form
TABLET
Route
ORAL
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Application
ANDA202330
Marketing category
ANDA
Marketing start
2015-06-30
Substance
BUSPIRONE HYDROCHLORIDE
Active strength
10 mg/1
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 5 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A202330-001BUSPIRONE HYDROCHLORIDEBUSPIRONE HYDROCHLORIDE5MGTABLET / ORALAB2014-08-25
A202330-002BUSPIRONE HYDROCHLORIDEBUSPIRONE HYDROCHLORIDE10MGTABLET / ORALAB2014-08-25
A202330-003BUSPIRONE HYDROCHLORIDEBUSPIRONE HYDROCHLORIDE15MGTABLET / ORALAB2014-08-25
A202330-004BUSPIRONE HYDROCHLORIDEBUSPIRONE HYDROCHLORIDE30MGTABLET / ORALAB2014-08-25
A202330-005BUSPIRONE HYDROCHLORIDEBUSPIRONE HYDROCHLORIDE7.5MGTABLET / ORALAB2017-02-17

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 5 matching rows.

Application-product, TE code table
Application-productTE code
A202330-001AB
A202330-002AB
A202330-003AB
A202330-004AB
A202330-005AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 6 · 215 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A202330-001BUSPIRONE HYDROCHLORIDE5MGTABLET / ORALAB2014-08-2584e616aacf4f…
2026-09-14 22:38:342026-08A202330-002BUSPIRONE HYDROCHLORIDE10MGTABLET / ORALAB2014-08-2584e616aacf4f…
2026-09-14 22:38:342026-08A202330-003BUSPIRONE HYDROCHLORIDE15MGTABLET / ORALAB2014-08-2584e616aacf4f…
2026-09-14 22:38:342026-08A202330-004BUSPIRONE HYDROCHLORIDE30MGTABLET / ORALAB2014-08-2584e616aacf4f…
2026-09-14 22:38:342026-08A202330-005BUSPIRONE HYDROCHLORIDE7.5MGTABLET / ORALAB2017-02-1784e616aacf4f…
2026-08-18 06:07:402026-07A202330-001BUSPIRONE HYDROCHLORIDE5MGTABLET / ORALAB2014-08-25caaa826d4ba7…
2026-08-18 06:07:402026-07A202330-002BUSPIRONE HYDROCHLORIDE10MGTABLET / ORALAB2014-08-25caaa826d4ba7…
2026-08-18 06:07:402026-07A202330-003BUSPIRONE HYDROCHLORIDE15MGTABLET / ORALAB2014-08-25caaa826d4ba7…
2026-08-18 06:07:402026-07A202330-004BUSPIRONE HYDROCHLORIDE30MGTABLET / ORALAB2014-08-25caaa826d4ba7…
2026-08-18 06:07:402026-07A202330-005BUSPIRONE HYDROCHLORIDE7.5MGTABLET / ORALAB2017-02-17caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A202330-001BUSPIRONE HYDROCHLORIDE5MGTABLET / ORALAB2014-08-25011fe1cb6892…
2026-02-19 14:30 UTC2026-02A202330-002BUSPIRONE HYDROCHLORIDE10MGTABLET / ORALAB2014-08-25011fe1cb6892…
2026-02-19 14:30 UTC2026-02A202330-003BUSPIRONE HYDROCHLORIDE15MGTABLET / ORALAB2014-08-25011fe1cb6892…
2026-02-19 14:30 UTC2026-02A202330-004BUSPIRONE HYDROCHLORIDE30MGTABLET / ORALAB2014-08-25011fe1cb6892…
2026-02-19 14:30 UTC2026-02A202330-005BUSPIRONE HYDROCHLORIDE7.5MGTABLET / ORALAB2017-02-17011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A202330-001BUSPIRONE HYDROCHLORIDE5MGTABLET / ORALAB2014-08-2531067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A202330-002BUSPIRONE HYDROCHLORIDE10MGTABLET / ORALAB2014-08-2531067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A202330-003BUSPIRONE HYDROCHLORIDE15MGTABLET / ORALAB2014-08-2531067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A202330-004BUSPIRONE HYDROCHLORIDE30MGTABLET / ORALAB2014-08-2531067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A202330-005BUSPIRONE HYDROCHLORIDE7.5MGTABLET / ORALAB2017-02-1731067a03dcf5…
2025-08-23 18:47 UTC2025-08A202330-001BUSPIRONE HYDROCHLORIDE5MGTABLET / ORALAB2014-08-256a471c1ec25d…
2025-08-23 18:47 UTC2025-08A202330-002BUSPIRONE HYDROCHLORIDE10MGTABLET / ORALAB2014-08-256a471c1ec25d…
2025-08-23 18:47 UTC2025-08A202330-003BUSPIRONE HYDROCHLORIDE15MGTABLET / ORALAB2014-08-256a471c1ec25d…
2025-08-23 18:47 UTC2025-08A202330-004BUSPIRONE HYDROCHLORIDE30MGTABLET / ORALAB2014-08-256a471c1ec25d…
2025-08-23 18:47 UTC2025-08A202330-005BUSPIRONE HYDROCHLORIDE7.5MGTABLET / ORALAB2017-02-176a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A202330-001BUSPIRONE HYDROCHLORIDE5MGTABLET / ORALAB2014-08-25fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A202330-002BUSPIRONE HYDROCHLORIDE10MGTABLET / ORALAB2014-08-25fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A202330-003BUSPIRONE HYDROCHLORIDE15MGTABLET / ORALAB2014-08-25fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A202330-004BUSPIRONE HYDROCHLORIDE30MGTABLET / ORALAB2014-08-25fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A202330-005BUSPIRONE HYDROCHLORIDE7.5MGTABLET / ORALAB2017-02-17fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A202330-001BUSPIRONE HYDROCHLORIDE5MGTABLET / ORALAB2014-08-25b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A202330-002BUSPIRONE HYDROCHLORIDE10MGTABLET / ORALAB2014-08-25b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A202330-003BUSPIRONE HYDROCHLORIDE15MGTABLET / ORALAB2014-08-25b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A202330-004BUSPIRONE HYDROCHLORIDE30MGTABLET / ORALAB2014-08-25b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A202330-005BUSPIRONE HYDROCHLORIDE7.5MGTABLET / ORALAB2017-02-17b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A202330-001BUSPIRONE HYDROCHLORIDE5MGTABLET / ORALAB2014-08-2503ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A202330-002BUSPIRONE HYDROCHLORIDE10MGTABLET / ORALAB2014-08-2503ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A202330-003BUSPIRONE HYDROCHLORIDE15MGTABLET / ORALAB2014-08-2503ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A202330-004BUSPIRONE HYDROCHLORIDE30MGTABLET / ORALAB2014-08-2503ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A202330-005BUSPIRONE HYDROCHLORIDE7.5MGTABLET / ORALAB2017-02-1703ed91905a0d…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 6 · 215 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08A202330-001AB184e616aacf4f…
2026-09-14 22:38:342026-08A202330-002AB184e616aacf4f…
2026-09-14 22:38:342026-08A202330-003AB184e616aacf4f…
2026-09-14 22:38:342026-08A202330-004AB184e616aacf4f…
2026-09-14 22:38:342026-08A202330-005AB184e616aacf4f…
2026-08-18 06:07:402026-07A202330-001AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A202330-002AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A202330-003AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A202330-004AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A202330-005AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A202330-001AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A202330-002AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A202330-003AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A202330-004AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A202330-005AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A202330-001AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A202330-002AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A202330-003AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A202330-004AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A202330-005AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A202330-001AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A202330-002AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A202330-003AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A202330-004AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A202330-005AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A202330-001AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A202330-002AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A202330-003AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A202330-004AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A202330-005AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A202330-001AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A202330-002AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A202330-003AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A202330-004AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A202330-005AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A202330-001AB103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A202330-002AB103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A202330-003AB103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A202330-004AB103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A202330-005AB103ed91905a0d…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Buspirone Hydrochloride
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
BUSPIRONE HYDROCHLORIDE10 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
207LT9J9OCInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
866083Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
093b701d-4a43-4871-b726-c5820fa3ab95Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
a9968269-ddf2-400e-9170-7376dcf3545aProduct name120251215
2cf3c2e9-d566-c982-009a-188fe4f776b9Product name820200428
4a9096ce-7b98-89e5-5942-15f48c4f7abfProduct name520190711

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
71610-257-53Buspirone Hydrochloride60 in 1 BOTTLETABLET602
71610-257-60Buspirone Hydrochloride90 in 1 BOTTLETABLET902
71610-257-80Buspirone Hydrochloride180 in 1 BOTTLETABLET1802
71610-257-92Buspirone Hydrochloride270 in 1 BOTTLETABLET2702

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
71610-257-53EA - Each71610-257c013d160-2765-49cc-9f9f-9c0a18522dc812019-06-19
71610-257-60EA - Each71610-2576683f890-6358-4bb6-bacc-f4ad206b594212019-06-19
71610-257-80EA - Each71610-257d123999b-ad0f-4c9a-8884-a32dce82c3c212019-06-19
71610-257-92EA - Each71610-25734687e69-06c6-4882-a0d4-f17b19acf29812026-05-22

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
71610-257BUSPIRONE HYDROCHLORIDE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]1Current NDC, Legacy NDC, 4 package rows20190409_093b701d-4a43-4871-b726-c5820fa3ab95.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 19 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Buspirone HydrochlorideBUSPIRONE HYDROCHLORIDEGolden State Medical Supply, Inc.bcce49d3-c8eb-9f9b-e053-2995a90a67d92026-07-27Warnings, Adverse reactionsExact identifier
application applno (ANDA): 202330
application number: ANDA202330
Buspirone HydrochlorideBUSPIRONE HYDROCHLORIDEStrides Pharma Inc.cb0091ad-97f6-431b-b2b9-e03171eed2742026-07-08Warnings, Adverse reactionsExact identifier
application applno (ANDA): 202330
application number: ANDA202330
Buspirone HydrochlorideBUSPIRONE HYDROCHLORIDEREMEDYREPACK INC.b42cc365-6259-4d2e-9648-d37718b65e1e2026-06-30Warnings, Adverse reactionsExact identifier
application applno (ANDA): 202330
application number: ANDA202330
Buspirone HydrochlorideBUSPIRONE HYDROCHLORIDENuCare Pharmaceuticals, Inc.50b18368-d37c-374b-e063-6394a90a81142026-04-30Warnings, Adverse reactionsExact identifier
application applno (ANDA): 202330
application number: ANDA202330
Buspirone HydrochlorideBUSPIRONE HYDROCHLORIDEAphena Pharma Solutions - Tennessee, LLC093b701d-4a43-4871-b726-c5820fa3ab952026-04-14Warnings, Adverse reactionsExact identifier
application applno (ANDA): 202330
application number: ANDA202330
ndc (package): 71610-257-53
ndc (product): 71610-257
ndc11 (package): 71610025753
BUSPIRONE HYDROCHLORIDEBUSPIRONE HYDROCHLORIDEDIRECT RXbae98d45-e192-56e3-e053-2a95a90aadc32026-03-05Warnings, Adverse reactionsExact identifier
application applno (ANDA): 202330
application number: ANDA202330
Buspirone HydrochlorideBUSPIRONE HYDROCHLORIDEA-S Medication Solutionsecdfd79e-7450-40ec-9561-cdda3a0439902026-01-28Warnings, Adverse reactionsExact identifier
application applno (ANDA): 202330
application number: ANDA202330
Buspirone HydrochlorideBUSPIRONE HYDROCHLORIDEA-S Medication Solutions4d1ae09a-3ead-4604-8d13-590f41f63b962026-01-28Warnings, Adverse reactionsExact identifier
application applno (ANDA): 202330
application number: ANDA202330
Buspirone HydrochlorideBUSPIRONE HYDROCHLORIDENorthwind Health Company, LLCd9de7cf1-c38d-8b3c-e053-2995a90aa26b2026-01-01Warnings, Adverse reactionsExact identifier
application applno (ANDA): 202330
application number: ANDA202330
Buspirone HydrochlorideBUSPIRONE HYDROCHLORIDEStrides Pharma Science Limitedcff9f09a-1ea2-4968-b57b-e62bebaae2382025-09-02Warnings, Adverse reactionsExact identifier
application applno (ANDA): 202330
application number: ANDA202330
Buspirone HydrochlorideBUSPIRONE HYDROCHLORIDEAphena Pharma Solutions - Tennessee, LLC1790d63d-ecb1-da9d-e063-6294a90a50ba2025-08-19Warnings, Adverse reactionsExact identifier
application applno (ANDA): 202330
application number: ANDA202330
Buspirone HydrochlorideBUSPIRONE HYDROCHLORIDEBryant Ranch Prepack63e2d4e2-f1ab-480d-b0bb-79b6cdb57a5d2025-05-12Warnings, Adverse reactionsExact identifier
application applno (ANDA): 202330
application number: ANDA202330
Buspirone HCLBUSPIRONE HCLDirect_Rxf83219c9-8081-fe55-e053-6394a90aa9242025-01-22Warnings, Adverse reactionsExact identifier
application applno (ANDA): 202330
application number: ANDA202330
Buspirone HydrochlorideBUSPIRONE HYDROCHLORIDENCS HealthCare of KY, LLC dba Vangard Labsda6f4a74-a71e-4ccc-af2c-8de29e909c3b2024-08-12Warnings, Adverse reactionsExact identifier
application applno (ANDA): 202330
application number: ANDA202330
Buspirone HydrochlorideBUSPIRONE HYDROCHLORIDEProficient Rx LP24a95296-5fbe-49df-b1fe-4760d3a5ffe12022-07-01Warnings, Adverse reactionsExact identifier
application applno (ANDA): 202330
application number: ANDA202330
Buspirone HydrochlorideBUSPIRONE HYDROCHLORIDEAphena Pharma Solutions - Tennessee, LLC0d46cf24-07e1-4bb7-8b5b-5ce12a030afd2022-03-16Warnings, Adverse reactionsExact identifier
application applno (ANDA): 202330
application number: ANDA202330
Buspirone HydrochlorideBUSPIRONE HYDROCHLORIDEAphena Pharma Solutions - Tennessee, LLC62e4345a-2c51-4f93-89f0-282895ced7852021-11-08Warnings, Adverse reactionsExact identifier
application applno (ANDA): 202330
application number: ANDA202330
Buspirone HydrochlorideBUSPIRONE HYDROCHLORIDEAphena Pharma Solutions - Tennessee, LLCfbab1056-b63e-473e-9259-ba099d884d2b2021-10-28Warnings, Adverse reactionsExact identifier
application applno (ANDA): 202330
application number: ANDA202330
Buspirone HydrochlorideBUSPIRONE HYDROCHLORIDEAphena Pharma Solutions - Tennessee, LLCfa8171d4-f73c-4a91-973d-cb46c55070812021-09-29Warnings, Adverse reactionsExact identifier
application applno (ANDA): 202330
application number: ANDA202330

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
866083busPIRone HCl 10 MG Oral TabletPSN093b701d-4a43-4871-b726-c5820fa3ab952
866083buspirone hydrochloride 10 MG Oral TabletSCD093b701d-4a43-4871-b726-c5820fa3ab952
866083buspirone HCl 10 MG (buspirone 9.1 MG) Oral TabletSY093b701d-4a43-4871-b726-c5820fa3ab952

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
71610-257-537161002575360 TABLET in 1 BOTTLE (71610-257-53) 60 tablet2019-03-290000-00-00NoNoCurrent